BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 29-Jan-2018

(Q2 Un-audited): Consolidated EPS was Tk. 0.97 for October-December, 2017 as against Tk. 1.29 for October-December, 2016; Consolidated EPS was Tk. 2.07 for July-December, 2017 as against Tk. 2.46 for July-December, 2016. Consolidated NOCFPS was Tk. 4.81 for July-December, 2017 as against Tk. 3.22 for July-December, 2016. (cont.)

ORIONPHARM 23-Jan-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2018 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017.

ORIONPHARM 17-Jan-2018

The Company has informed that it has disbursed cash dividend for the year ended on June 30, 2017.

ORIONPHARM 29-Nov-2017

Trading of the shares of the Company will resume on 30.11.2017 after record date.

ORIONPHARM 28-Nov-2017

Trading of the shares of the Company will remain suspended on record date i.e., 29.11.2017.

ORIONPHARM 26-Nov-2017

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 27.11.2017 to 28.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 29.11.2017.

ORIONPHARM 15-Nov-2017

(Q1 Un-audited): Consolidated EPS was Tk. 1.10 for July-September, 2017 as against Tk. 1.17 for July-September, 2016; Consolidated NOCFPS was Tk. 2.53 for July-September, 2017 as against Tk. 1.33 for July-September, 2016. Consolidated NAV per share (including revaluation surplus) was Tk. 72.05 as on September 30, 2017 and Tk. 71.09 as on September 30, 2016. Consolidated NAV per share (excluding revaluation surplus) was Tk. 63.62 as on September 30, 2017 and Tk. 62.51 as on September 30, 2016.

ORIONPHARM 08-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

ORIONPHARM 08-Nov-2017

There will be no price limit on the trading of the shares of the Company today (08.11.2017) following its corporate declaration.

ORIONPHARM 08-Nov-2017

The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2017. Date of AGM: 14.12.2017, Time: 10:30 AM, Venue: Officer's Club, 26, Baily Road, Ramna, Dhaka. Record Date: 29.11.2017. The Company has also reported Consolidated EPS of Tk. 3.40, Consolidated NAV per share (including Revaluation Surplus) of Tk. 70.95 and Consolidated NOCFPS of Tk. 9.62 for the year ended on June 30, 2017 as against Tk. 5.65, Tk. 69.99 and Tk. 16.62 respectively for the year ended on June 30, 2016.

Previous Next page